SIRT3 overexpression is also involved in inhibiting pancreatic cancer cell growth by inhibiting iron-regulatory protein 1 (IRP1) enrichment, thereby suppressing transferrin receptor 1 (TfR1) and TfR1-mediated iron uptake and cell growth [140]. Here, TFRC is linked to familial pancreatic carcinoma.